Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
Aulitzky
W E
WE
Tilg
H
H
Niederwieser
D
D
Hackl
M
M
Meister
B
B
Huber
C
C
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D015774:Ganciclovir; D006801:Humans; D007116:Immunization, Passive; D011024:Pneumonia, Viral / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D011183:Postoperative Complications / Q000188:drug therapy*
D000998:Antiviral Agents; D015774:Ganciclovir; D000212:Acyclovir